These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31776384)

  • 1. Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content.
    Tonin R; Caciotti A; Procopio E; Fischetto R; Deodato F; Mancardi MM; Di Rocco M; Ardissone A; Salviati A; Marangi A; Strisciuglio P; Mangone G; Casini A; Ricci S; Fiumara A; Parini R; Pavone FS; Guerrini R; Calamai M; Morrone A
    Sci Rep; 2019 Nov; 9(1):17684. PubMed ID: 31776384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience.
    Fischetto R; Palladino V; Mancardi MM; Giacomini T; Palladino S; Gaeta A; Di Rocco M; Zampini L; Lassandro G; Favia V; Tripaldi ME; Strisciuglio P; Romano A; Severino M; Morrone A; Giordano P
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1371. PubMed ID: 32779865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Drug Candidates Improve Ganglioside Accumulation and Neural Dysfunction in GM1 Gangliosidosis Models with Autophagy Activation.
    Kajihara R; Numakawa T; Odaka H; Yaginuma Y; Fusaki N; Okumiya T; Furuya H; Inui S; Era T
    Stem Cell Reports; 2020 May; 14(5):909-923. PubMed ID: 32302553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The metabolism of radiolabelled GM1-ganglioside in cultured skin fibroblasts from controls and patients with GM1-gangliosidosis].
    Inui K
    Nihon Rinsho; 1995 Dec; 53(12):3102-4. PubMed ID: 8577066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake and metabolism of radiolabelled GM1-ganglioside in skin fibroblasts from controls and patients with GM1-gangliosidosis.
    Midorikawa M; Inui K; Okada S; Yabuuchi H; Ogura K; Handa S
    J Inherit Metab Dis; 1991; 14(5):721-9. PubMed ID: 1779618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent In Situ Staining and Flow Cytometric Procedures as New Pre-Diagnostic Tests for Sialidosis, GM1 Gangliosidosis and Niemann-Pick Type C.
    Capitini C; Feo F; Caciotti A; Tonin R; Lulli M; Coviello D; Guerrini R; Calamai M; Morrone A
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen.
    Satoh H; Yamato O; Asano T; Yonemura M; Yamauchi T; Hasegawa D; Orima H; Arai T; Yamasaki M; Maede Y
    Brain Res; 2007 Feb; 1133(1):200-8. PubMed ID: 17196562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclodextrins on GM1-gangliosides in fibroblasts from GM1-gangliosidosis patients.
    Maeda Y; Motoyama K; Higashi T; Horikoshi Y; Takeo T; Nakagata N; Kurauchi Y; Katsuki H; Ishitsuka Y; Kondo Y; Irie T; Furuya H; Era T; Arima H
    J Pharm Pharmacol; 2015 Aug; 67(8):1133-42. PubMed ID: 25851126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
    Kasperzyk JL; El-Abbadi MM; Hauser EC; D'Azzo A; Platt FM; Seyfried TN
    J Neurochem; 2004 May; 89(3):645-53. PubMed ID: 15086521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression.
    Deodato F; Procopio E; Rampazzo A; Taurisano R; Donati MA; Dionisi-Vici C; Caciotti A; Morrone A; Scarpa M
    Metab Brain Dis; 2017 Oct; 32(5):1529-1536. PubMed ID: 28577204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased concentration of GM1-ganglioside in cerebrospinal fluid in dogs with GM1- and GM2-gangliosidoses and its clinical application for diagnosis.
    Satoh H; Yamato O; Asano T; Yamasaki M; Maede Y
    J Vet Diagn Invest; 2004 May; 16(3):223-6. PubMed ID: 15152837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation and degradation of GM1 ganglioside and asialoGM1 ganglioside in cultured fibroblasts from normal individuals and patients with beta-galactosidase deficiency.
    Kobayashi T; Shinnoh N; Kuroiwa Y
    Biochim Biophys Acta; 1986 Jan; 875(1):115-21. PubMed ID: 3079639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased
    Percival BC; Latour YL; Tifft CJ; Grootveld M
    Cells; 2021 Mar; 10(3):. PubMed ID: 33807817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G(M1)-ganglioside degradation and biosynthesis in human and murine G(M1)-gangliosidosis.
    Sano R; Trindade VM; Tessitore A; d'Azzo A; Vieira MB; Giugliani R; Coelho JC
    Clin Chim Acta; 2005 Apr; 354(1-2):131-9. PubMed ID: 15748609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice.
    Kasperzyk JL; d'Azzo A; Platt FM; Alroy J; Seyfried TN
    J Lipid Res; 2005 Apr; 46(4):744-51. PubMed ID: 15687347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis.
    Allende ML; Lee YT; Byrnes C; Li C; Tuymetova G; Bakir JY; Nicoli ER; James VK; Brodbelt JS; Tifft CJ; Proia RL
    J Lipid Res; 2023 Dec; 64(12):100463. PubMed ID: 37871851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM1-gangliosidosis in a cross-bred dog confirmed by detection of GM1-ganglioside using electrospray ionisation-tandem mass spectrometry.
    Whitfield P; Johnson AW; Dunn KA; Delauche AJ; Winchester BG; Franklin RJ
    Acta Neuropathol; 2000 Oct; 100(4):409-14. PubMed ID: 10985700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy.
    Rigat BA; Tropak MB; Buttner J; Crushell E; Benedict D; Callahan JW; Martin DR; Mahuran DJ
    Mol Genet Metab; 2012 Sep; 107(1-2):203-12. PubMed ID: 22784478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Pathobiology of GM1 Gangliosidosis from Single-Nucleus Transcriptomic Analysis of CNS Cells in a Mouse Model.
    Liu S; Xie T; Huang Y
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile gangliosidoses: Mapping a timeline of clinical changes.
    Jarnes Utz JR; Kim S; King K; Ziegler R; Schema L; Redtree ES; Whitley CB
    Mol Genet Metab; 2017 Jun; 121(2):170-179. PubMed ID: 28476546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.